Online inquiry

IVTScrip™ mRNA-Human ADGRF5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7740MR)

This product GTTS-WK7740MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ADGRF5 protein. This product can be used in MKI67+ progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001098518.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 221395
UniProt ID Q8IZF2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADGRF5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7740MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25540MR IVTScrip™ mRNA-Human APOPT1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APOPT1
GTTS-WK23880MR IVTScrip™ mRNA-Human ARRDC3, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARRDC3
GTTS-WK21209MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK15507MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK17607MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK19466MR IVTScrip™ mRNA-Human ANXA8, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANXA8
GTTS-WK10145MR IVTScrip™ mRNA-Human ADGRL1, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRL1
GTTS-WK10759MR IVTScrip™ mRNA-Human ADORA2A, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADORA2A
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →